Cargando…
Tumorigenic transformation of human prostatic epithelial cell line RWPE‐1 by growth hormone‐releasing hormone (GHRH)
BACKGROUND: Growth hormone‐releasing hormone (GHRH) and its receptors have been implicated in the progression of various tumors. In this study, we analyzed the carcinogenetic potential of exposure to GHRH of a nontumor human prostate epithelial cell line (RWPE‐1) as well as its transforming effect i...
Autores principales: | Muñoz‐Moreno, Laura, Carmena, M. José, Prieto, Juan C., Schally, Andrew V., Bajo, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310601/ https://www.ncbi.nlm.nih.gov/pubmed/35322894 http://dx.doi.org/10.1002/pros.24339 |
Ejemplares similares
-
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer
por: Muñoz-Moreno, Laura, et al.
Publicado: (2016) -
Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1
por: Cui, Tengjiao, et al.
Publicado: (2018) -
SAT-603 Growth Hormone-Releasing Hormone (GHRH) Antagonists Stimulate Feeding in Mice
por: Leone, Sheila, et al.
Publicado: (2020) -
Protective effects of agonists of growth hormone-releasing hormone (GHRH) in early experimental diabetic retinopathy
por: Thounaojam, Menaka C., et al.
Publicado: (2017) -
Antiproliferative effect of growth hormone-releasing hormone (GHRH) antagonist on ovarian cancer cells through the EGFR-Akt pathway
por: Guo, Jian, et al.
Publicado: (2010)